With this show, we aim to familiarize you with not only ABclonal’s contributions to efforts in scientific discovery, but also to highlight the direction of ongoing bioscience research and to help scientists determine how best to leverage their skills to improve global human health and quality of life.
All content for BioChat, a Podcast by ABclonal Technology is the property of ABclonal Technology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
With this show, we aim to familiarize you with not only ABclonal’s contributions to efforts in scientific discovery, but also to highlight the direction of ongoing bioscience research and to help scientists determine how best to leverage their skills to improve global human health and quality of life.
BioChat #15: Working Toward Improved Treatments For Alzheimer’s Disease
BioChat, a Podcast by ABclonal Technology
45 minutes 43 seconds
2 years ago
BioChat #15: Working Toward Improved Treatments For Alzheimer’s Disease
Kin invites Dr. Lei Liu, MD, PhD, from Harvard University to learn more about Alzheimer's Disease and the ongoing work to develop more effective treatments towards improved standards of living for the afflicted and perhaps and eventual cure. We discuss the pathology of Alzheimer's Disease, novel biomarkers, and new directions in Alzheimer's research, with plenty of insights from Dr. Liu.
November is Alzheimer's Awareness Month! You can learn more about how you can help from the Alzheimer's Association and donate what you can at ENDALZ.org.
Please feel free to visit us at www.abclonal.com, read our blog posts here, including some updates on innovative Alzheimer treatment strategies, and check out our Doctor Beaker page for fun activities! You can also find all the ways to subscribe to our podcast via our BioChat page, which includes Apple Podcasts and Spotify.
BioChat, a Podcast by ABclonal Technology
With this show, we aim to familiarize you with not only ABclonal’s contributions to efforts in scientific discovery, but also to highlight the direction of ongoing bioscience research and to help scientists determine how best to leverage their skills to improve global human health and quality of life.
